387 related articles for article (PubMed ID: 34299325)
21. Cells of extramammary Paget's disease express cytokeratins different from those of epidermal cells.
Moll I; Moll R
J Invest Dermatol; 1985 Jan; 84(1):3-8. PubMed ID: 2578171
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
[TBL] [Abstract][Full Text] [Related]
23. Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell.
Tohmatsu Y; Imura J; Sakai T; Takagi K; Minamisaka T; Tanaka S; Noguchi A; Nakajima T; Nagata T; Makino T; Shimizu T; Fujii T
APMIS; 2021 Jan; 129(1):3-8. PubMed ID: 32996218
[TBL] [Abstract][Full Text] [Related]
24. Distinguishing tumour cells of mammary from extramammary Paget's disease using antibodies to two different glycoproteins from human milk-fat-globule membrane.
Imam A; Yoshida SO; Taylor CR
Br J Cancer; 1988 Sep; 58(3):373-8. PubMed ID: 2846025
[TBL] [Abstract][Full Text] [Related]
25. Treatment of limited extent extramammary Paget's disease with 5 percent imiquimod cream.
Badgwell C; Rosen T
Dermatol Online J; 2006 Jan; 12(1):22. PubMed ID: 16638390
[TBL] [Abstract][Full Text] [Related]
26. Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease.
Kang Z; Xu F; Zhang QA; Lin J; Wu Z; Zhang X; Luo Y; Xu J; Guan M
Mod Pathol; 2012 Aug; 25(8):1160-8. PubMed ID: 22522847
[TBL] [Abstract][Full Text] [Related]
27. Treatment of mammary and extramammary Paget's skin disease with topical imiquimod.
Mirer E; El Sayed F; Ammoury A; Lamant L; Messer L; Bazex J
J Dermatolog Treat; 2006; 17(3):167-71. PubMed ID: 16854759
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease.
Azmahani A; Nakamura Y; Ozawa Y; McNamara KM; Fujimura T; Haga T; Hashimoto A; Aiba S; Sasano H
Hum Pathol; 2015 Nov; 46(11):1662-9. PubMed ID: 26359540
[TBL] [Abstract][Full Text] [Related]
30. The expression of HER-2 in extramammary Paget's disease.
Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
[TBL] [Abstract][Full Text] [Related]
31. Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo.
Perrone E; Manara P; Lopez S; Bellone S; Bonazzoli E; Manzano A; Zammataro L; Bianchi A; Zeybek B; Buza N; Tymon-Rosario J; Altwerger G; Han C; Menderes G; Huang GS; Ratner E; Silasi DA; Azodi M; Hui P; Schwartz PE; Scambia G; Santin AD
Mol Oncol; 2020 Mar; 14(3):645-656. PubMed ID: 31891442
[TBL] [Abstract][Full Text] [Related]
32. Extramammary Paget's disease: a report of three cases and review of the literature.
Png JC; Tung KH; Wong YE; Mokal N; Rajagopalan R; Chong PY
Ann Acad Med Singap; 1995 Jul; 24(4):636-9. PubMed ID: 8849202
[TBL] [Abstract][Full Text] [Related]
33. Extramammary Paget's disease: comparative histopathologic studies of intraductal carcinoma of the breast and apocrine adenocarcinoma.
Urabe A; Matsukuma A; Shimizu N; Nishimura M; Wada H; Hori Y
J Cutan Pathol; 1990 Oct; 17(5):257-65. PubMed ID: 2175320
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical and clinicopathological study regarding nardilysin on extramammary Paget's disease.
Yamaguchi A; Takahashi T; Kato T; Tanaka T; Nishi E; Fujimoto N
Arch Dermatol Res; 2023 Sep; 315(7):1979-1987. PubMed ID: 36867223
[TBL] [Abstract][Full Text] [Related]
35. Expression of histo-blood group A type 1, 2 and 3 antigens in normal skin and extramammary Paget's disease.
Tanaka A; Kimura A; Yamamoto Y; Uede K; Furukawa F
Acta Histochem Cytochem; 2008 Dec; 41(6):165-71. PubMed ID: 19180201
[TBL] [Abstract][Full Text] [Related]
36. The Rise of the TROP2-Targeting Agents in NSCLC: New Options on the Horizon.
Ahmed Y; Berenguer-Pina JJ; Mahgoub T
Oncology; 2021; 99(10):673-680. PubMed ID: 34280931
[TBL] [Abstract][Full Text] [Related]
37. First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors.
Starodub AN; Ocean AJ; Shah MA; Guarino MJ; Picozzi VJ; Vahdat LT; Thomas SS; Govindan SV; Maliakal PP; Wegener WA; Hamburger SA; Sharkey RM; Goldenberg DM
Clin Cancer Res; 2015 Sep; 21(17):3870-8. PubMed ID: 25944802
[TBL] [Abstract][Full Text] [Related]
38. MiR-155, a potential serum marker of extramammary Paget's disease.
Guo H; Qi RQ; Sheng J; Liu C; Ma H; Wang HX; Li JH; Gao XH; Wan YS; Chen HD
BMC Cancer; 2018 Nov; 18(1):1078. PubMed ID: 30458743
[TBL] [Abstract][Full Text] [Related]
39. PI3K, Rac1 and pPAK1 are overexpressed in extramammary Paget's disease.
Qian Y; Zhang N; Chen S; Chu S; Feng A; Liu H
J Cutan Pathol; 2012 Nov; 39(11):1010-5. PubMed ID: 22845716
[TBL] [Abstract][Full Text] [Related]
40. ALA-PDT as palliative care in a patient with secondary perineum EMPD.
Shen S; Zhang G; Wang P; Zhang Y; Keyal U; Ji J; Wang X
Photodiagnosis Photodyn Ther; 2018 Jun; 22():166-168. PubMed ID: 29627436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
